Randomized Controlled Trials - COMPAR-EU - Liferay

Randomized Controlled Trials - COMPAR-EU

COMPAR-EU RCTs Web

Keywords

Outcome

Measure

Country

Advanced search

Publication title	Author	Disease	Self-management interventions	Outcomes measured in the study
Effectiveness of a combined exercise training and home-based walking programme on physical activity compared with standard medical care in moderate COPD: a randomised controlled trial	de Roos, P.	COPD	Shared decision making delivered in groups	Physical activity / Muscle strenght
Clinical benefits of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease	de Sousa Pinto, J. M.	COPD	Education based intervention	Activities of daily living, COPD symptoms (short term), Physical activity / Muscle strenght, Qualiy of life
Physical activity is increased by a 12-week semiautomated telecoaching programme in patients with COPD: A multicentre randomised controlled trial	Demeyer, H.	COPD	Monitoring, action-based and emotional-based behavioural techniques	Physical activity / Muscle strenght, Qualiy of life
The effect of non-pharmacological staged interventions on fatigue and dyspnoea in patients with chronic obstructive pulmonary disease: a randomized controlled trial	Deng, G.	COPD	Monitoring techniques, emotional-based behavioural techniques and social support	COPD symptoms (short term)

Toont 41 - 44 van 1.704 resultaten.

Vorige pagina
Pagina1
Tussenpagina's
- Pagina2
- Pagina3
- Pagina4
- Pagina5
- Pagina6
- Pagina7
- Pagina8
- Pagina9
Pagina10
Pagina11
Pagina12
Tussenpagina's
- Pagina13
- Pagina14
- Pagina15
- Pagina16
- Pagina17
- Pagina18
- Pagina19
- Pagina20
- Pagina21
- Pagina22
- Pagina23
- Pagina24
- Pagina25
- Pagina26
- Pagina27
- Pagina28
- Pagina29
- Pagina30
- Pagina31
- Pagina32
Pagina426
Volgende pagina

2020© COMPAR-EU

Dit platform is ontwikkeld als onderdeel van het COMPAR-EU project.
Het COMPAR-EU project heeft financiering ontvangen van het Horizon 2020 onderzoeks- en innovatieprogramma van de Europese Unie in het kader van subsidie overeenkomst nummer 754936.

Houd er rekening mee dat dit de bètaversie van het COMPAR-EU-platform is. Het bevat nu de voltooide resultaten voor Diabetes Type 2 en gedurende de zomer van 2022 zullen de resultaten voor obesitas, COPD en hartfalen worden voltooid. Ook wordt het platform de komende maanden uitgebreid en verbeterd.

Privacy beleid Cookies beleid

ComparEuHomePopupWeb